Panel talk about Inify’s fourth quarter 2022
During the last quarter of 2022, Inify Laboratories moved into its brand-new premises at Campus Solna just outside of Stockholm. The laboratory was finished in record time and all essential […]
Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time
STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has completed its new laboratory – including staffing up with skilled […]
Panel talk about Inify’s third quarter
The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping […]
Inify Laboratories – Laboratory and recruitment on track with positive market feedback
STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated […]
Inify Laboratories AB (publ) – Extraordinary General Meeting
Stockholm, Sweden, August 30, 2022; Today, the 30th of August 2022, Inify Laboratories AB, org. no. 559345-4431, held an extraordinary general meeting in Stockholm. Total 31,807,064 shares were represented at […]
Inify Laboratories – mandatory notification of trade
Stockholm, Sweden, August 19, 2022 – Inify Laboratories AB (“Inify”) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: […]
Inify’s first ultramodern laboratory on track
STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on […]
Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)
STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda […]
Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)
STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda […]
Inify Laboratories announces the appointment of Chief Medical Officer (CMO)
Stockholm, June 29th 2022 Inify Laboratories announces the addition of specialized medical competence to the company’s management team and organization. “We warmly welcome Dr. Claes Lind to the role as […]